Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19.
Macaluso FS, Giuliano A, Fries W, Viola A, Abbruzzese A, Cappello M, Giuffrida E, Carrozza L, Privitera AC, Magnano A, Ferracane C, Scalisi G, Minissale MG, Giangreco E, Garufi S, Bertolami C, Cucinotta U, Graziano F, Casà A, Renna S, Teresi G, Rizzuto G, Mannino M, Maida M, Orlando A. Macaluso FS, et al. Among authors: cucinotta u. Inflamm Bowel Dis. 2023 Feb 1;29(2):217-221. doi: 10.1093/ibd/izac064. Inflamm Bowel Dis. 2023. PMID: 35385102 Free PMC article.
Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease: data from the Sicilian Network for Inflammatory Bowel Disease.
Dipasquale V, Pellegrino S, Ventimiglia M, Cucinotta U, Citrano M, Graziano F, Cappello M, Busacca A, Orlando A, Accomando S, Romano C; Sicilian Network for Inflammatory Bowel Disease. Dipasquale V, et al. Among authors: cucinotta u. Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1007-1014. doi: 10.1097/MEG.0000000000002408. Epub 2022 Jul 14. Eur J Gastroenterol Hepatol. 2022. PMID: 35830365
Clinical Course of Very Early-Onset Inflammatory Bowel Disease.
Cucinotta U, Arrigo S, Dipasquale V, Gramaglia SMC, Laganà F, Romano C, Gandullia P. Cucinotta U, et al. J Pediatr Gastroenterol Nutr. 2023 May 1;76(5):590-595. doi: 10.1097/MPG.0000000000003730. Epub 2023 Feb 7. J Pediatr Gastroenterol Nutr. 2023. PMID: 36754082
Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD.
Sila S, Aloi M, Cucinotta U, Gianolio L, Granot M, Hradsky O, Hussey S, Kang B, Karoliny A, Kolho KL, de Laffolie J, Lega S, Matar M, Norsa L, Omiwole S, Orlanski-Meyer E, Palomino L, Rohani P, Scarallo L, Sladek M, Sohouli MH, Urlep D, Yerushalmy-Feler A, Zifman E, Hojsak I. Sila S, et al. Among authors: cucinotta u. Inflamm Bowel Dis. 2024 Jul 31:izae165. doi: 10.1093/ibd/izae165. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39083286
61 results